Verastem (VSTM) Revenue (2018 - 2026)

Verastem's Revenue history runs 8 years deep, the most recent figure standing at $18.7 million for Q1 2026.

• On a quarterly basis, Revenue changed N/A year-over-year to $18.7 million in Q1 2026; TTM through Mar 2026 was $49.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $30.9 million, up 209.14% from the prior year.
• Revenue rose to $18.7 million in Q1 2026 per VSTM's latest filing, from $17.5 million in the prior quarter.
• Across five years, Revenue topped out at $18.7 million in Q1 2026 and bottomed at $2.1 million in Q2 2025.
• The 4-year median for Revenue is $10.6 million (2024), against an average of $10.4 million.
• Across the five-year window, Revenue surged 158.05% in 2022 and plunged 78.63% in 2025, its largest moves.
• Year by year, Revenue stood at $2.6 million in 2022, then jumped by 285.21% to $10.0 million in 2024, then soared by 75.35% to $17.5 million in 2025, then increased by 6.48% to $18.7 million in 2026.
• Per Business Quant, the three latest VSTM Revenue figures stand at $18.7 million (Q1 2026), $17.5 million (Q4 2025), and $11.2 million (Q3 2025).